| 5864033 |
Adenosine kinase inhibitors |
Bheemarao G. Ugarkar, Kevin M. Mullane, Harry E. Gruber, David A. Bullough, Mark D. Erion +1 more |
1999-01-26 |
| 5777100 |
AICA riboside analogs |
David A. Bullough, Harry E. Gruber, Ernest K. Metzker, Kevin M. Mullane, Bheemarao G. Ugarkar |
1998-07-07 |
| 5763597 |
Orally active adenosine kinase inhibitors |
Bheemarao G. Ugarkar, Mark D. Erion, Jorge E. Gomez Galeno, Angelo Castellino |
1998-06-09 |
| 5721356 |
Orally active adenosine kinase inhibitors |
Bheemarao G. Ugarkar, Mark D. Erion, Jorge E. Gomez Galeno, Angelo Castellino |
1998-02-24 |
| 5658889 |
Method and compounds for aica riboside delivery and for lowering blood glucose |
Harry E. Gruber, Ronald R. Tuttle, Bheemarao G. Ugarkar, Jack W. Reich, Ernest K. Metzner +1 more |
1997-08-19 |
| 5646128 |
Methods for treating adenosine kinase related conditions |
Gary Firestein, Bheemarao G. Ugarkar, Leonard P. Miller, Harry E. Gruber, David A. Bullough +2 more |
1997-07-08 |
| 5460605 |
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
Ronald R. Tuttle |
1995-10-24 |
| 5395970 |
1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol |
Ronald R. Tuttle |
1995-03-07 |
| 5286252 |
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
Ronald R. Tuttle |
1994-02-15 |
| 5234404 |
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
Ronald R. Tuttle |
1993-08-10 |
| 5108363 |
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
Ronald R. Tuttle |
1992-04-28 |
| 5082829 |
AICA riboside prodrugs |
Harry E. Gruber, Bheemaro G. Vgarkar, Jack W. Reich |
1992-01-21 |